ArticleThoracic cancer2024

Real-world outcome of crizotinib for anaplastic lymphoma kinase-positive lung cancer: Multicenter retrospective analysis in South Korea.

Da Som Jeon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.